Ithaca College

University of California

The J. David Gladstone Institutes

Princeton University

Cornell University

Buck Institute for Research on Aging

Scott Michael Ulrich

Eric M Verdin

John Newman

Bonnie L Bassler

Lee R Swem

Colleen T O'Loughlin

Richard A Cerione

Clint A Stalnecker

Kristin Wilson Cerione

Brian J North

In various embodiments methods of preparing hydroxybutyryl 3-hydroxybutyrate and related compounds are provided along with methods of use thereof.

Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds

Aspects of the present disclosure include fatty acid &#x3b2;-hydroxyester compounds (e.g., fatty acid esters of &#x3b2;-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid &#x3b2;-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.

Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same

The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.

Inhibitors of kidney-type glutaminase, GLS-1

Medium chain fatty acid esters of &#x3b2;-hydroxybutyrate and butanediol and compositions and methods for using same

A novel small molecule antagonizes two types of acyl homoserine lactone receptors: membrane-bound and cytoplasmic. A focused library of analogs and derivatives of the original antagonist was synthesized. Analog and derivative molecules harbor a range of activities. The novel small molecule and most potent antagonist protects the eukaryotefrom quorum-sensing-mediated killing by the bacterial pathogen. The saving ofdemonstrates the use of these molecules as small molecule antimicrobials.

Small molecule antagonists of bacterial quorum-sensing receptors

The present invention provides methods for identifying agents that modulate a level or an activity of tubulin deacetylase polypeptide, as well as agents identified by the methods. The invention further provides methods of modulating tubulin deacetylase activity in a cell. The invention further provides methods of modulating cellular proliferation by modulating the activity of tubulin deacetylase.

Methods of modulating tubulin deacetylast activity

Methods of modulating tubulin deacetylase activity

Growing community of inventors

Brooktondale, NY, United States of America

Scott Michael Ulrich